CrushSCI.com
85.8Average days
2.5Median days
1Fastest days
370Longest days
4012025 publications

Paper Review Records

All Paper Review Records

6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

1 days

A Counterintuitive Approach to Cancer Therapy

Authors
René BernardsShow moreShow less
Affiliations
1. Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.Show moreShow less
Source PDF DOI Publisher page
1 days

Rare Fusions, Real Targets: Ultraprecision Oncology in Lung Cancer

Authors
Xiuning Le; Jürgen WolfShow moreShow less
Affiliations
1. The University of Texas MD Anderson Cancer Center 1 Thoracic Head and Neck Medical Oncology, , Houston, Texas.; 2. 2Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.Show moreShow less
Source PDF DOI Publisher page
3 days

Genomics of Subsequent Neoplasms in Childhood Cancer Survivors

Authors
Eline J.M. Bertrums; Ruben van BoxtelShow moreShow less
Affiliations
1. 1Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; 2. 2Oncode Institute, Utrecht, the Netherlands.; 3. 3Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.Show moreShow less
Source PDF DOI Publisher page
370 days

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-Driven Alveolar Rhabdomyosarcoma

Authors
Susu Zhang; Kathleen L. Engel; Assil Fahs; Ara Jo; Clare F. Malone; Kenneth N. Ross; Marissa Just; Brian Guedes; Diyana Granum; Kristianne M. Oristian; Alexander R. Kovach; Gabriela Alexe; Giulia DiGiovanni; Leen Barbar; Rex C. Bentley; Christian G. Cerda-Smith; Ozgun Le Roux; Elizabeth A. Mendes; Seth Parker Zimmerman; Audrey Taillon; Vivian Tong; Allen Basanthakumar; Matthew G. Rees; Jennifer A. Roth; Jack F. Shern; Kris C. Wood; Christopher M. Counter; Corinne M. Linardic; Kimberly StegmaierShow moreShow less
Affiliations
1. Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute , Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts.; 2. The Broad Institute of MIT and Harvard , Cambridge, Massachusetts.; 3. Division of Pediatric Hematology/Oncology, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.; 4. Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina.; 5. Department of Pathology, Duke University School of Medicine, Durham, North Carolina.; 6. Pediatric Oncology Branch, National Institutes of Health, Bethesda, Maryland.Show moreShow less
Source PDF DOI Publisher page
2 days

Spatially Resolved Proteomic Cartography Illuminates the Earliest Molecular Programs in Pancreatic Cancer Evolution

Authors
Mingyu Yang; Rong FanShow moreShow less
Affiliations
1. Yale University 1 Department of Biomedical Engineering, School of Engineering and Applied Science, , New Haven, Connecticut.; 2. Yale University 2 Department of Pathology, School of Medicine, , New Haven, Connecticut.; 3. Yale University 3 Yale Cancer Center, , New Haven, Connecticut.Show moreShow less
Source PDF DOI Publisher page
138 days

Pancreatic Cancer: Translating Tumor Biology into Actionability

Authors
Fiyinfolu O. Balogun; Mara H. Sherman; Wungki Park; Kevin C. Soares; Marsha Reyngold; Joshua D. Schoenfeld; Anupriya Singhal; Christine A. Iacobuzio-Donahue; Eileen M. O’ReillyShow moreShow less
Affiliations
1. Memorial Sloan Kettering Cancer Center 1 Department of Medicine, , New York, New York.; 2. Memorial Sloan Kettering Cancer Center 2 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York.; 3. 3Department of Medicine, Weill Cornell Medicine, New York, New York.; 4. Memorial Sloan Kettering Cancer Center 4 Cancer Biology and Genetics Program, Sloan Kettering Institute, , New York, New York.; 5. Memorial Sloan Kettering Cancer Center 5 Department of Surgery, , New York, New York.; 6. Memorial Sloan Kettering Cancer Center 6 Department of Radiation Oncology, , New York, New York.; 7. Memorial Sloan Kettering Cancer Center 7 Department of Pathology and Laboratory Medicine, , New York, New York.Show moreShow less
Source PDF DOI Publisher page

FAQ

How long does Cancer Discovery take to review a manuscript?

As of 2026-11-19, CrushSCI has 6 complete review records for Cancer Discovery. The fastest paper went from submission to acceptance in 1 days (A Counterintuitive Approach to Cancer Therapy, received 2026-06-04, accepted 2026-06-05); the slowest took 370 days. The average is 85.8 days and the median is 2.5 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.